Lin Mei Selected Research

dilactide

9/2014	Synthesis of cholic acid-core poly(ε-caprolactone-ran-lactide)-b-poly(ethylene glycol) 1000 random copolymer as a chemotherapeutic nanocarrier for liver cancer treatment.
8/2014	Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lin Mei Research Topics

Disease

100	Neoplasms (Cancer) 12/2022 - 07/2009
19	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2009
16	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 11/2004
14	Schizophrenia (Dementia Praecox) 01/2020 - 06/2008
12	Myasthenia Gravis 01/2021 - 04/2012
12	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2019 - 12/2012
10	Carcinogenesis 01/2021 - 08/2011
7	Wounds and Injuries (Trauma) 11/2022 - 12/2013
7	Lung Neoplasms (Lung Cancer) 01/2019 - 04/2015
6	Hepatocellular Carcinoma (Hepatoma) 03/2019 - 12/2013
5	Inflammation (Inflammations) 03/2022 - 09/2010
5	Neoplasm Metastasis (Metastasis) 10/2020 - 01/2014
5	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 05/2011
5	Hypoxia (Hypoxemia) 01/2020 - 09/2010
4	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 01/2021 - 10/2014
4	Liver Neoplasms (Liver Cancer) 05/2018 - 09/2014
4	Muscle Weakness 01/2018 - 12/2013
3	Hyperthermia 01/2022 - 01/2020
3	Bone Resorption 06/2021 - 07/2008
3	Glioma (Gliomas) 10/2020 - 08/2011
3	Bacterial Infections (Bacterial Infection) 01/2020 - 05/2014
3	Mental Disorders (Mental Disorder) 01/2018 - 03/2013
3	Glioblastoma (Glioblastoma Multiforme) 01/2012 - 04/2011
3	Diabetes Complications 10/2011 - 08/2004
2	Rupture 08/2022 - 01/2021
2	Pain (Aches) 01/2022 - 10/2013
2	Infections 01/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

36	Proteins (Proteins, Gene)FDA Link 06/2021 - 02/2007
27	Pharmaceutical PreparationsIBA 01/2022 - 01/2011
23	tocophersolanIBA 09/2019 - 05/2010
20	Docetaxel (Taxotere)FDA Link 09/2019 - 07/2009
14	AntibodiesIBA 01/2021 - 04/2012
13	polydopamineIBA 10/2021 - 01/2016
13	AgrinIBA 01/2021 - 10/2008
13	Succinic Acid (Succinate)IBA 09/2019 - 05/2010
12	Phosphorus (Red Phosphorus)IBA 04/2022 - 01/2017
12	neogeninIBA 01/2021 - 11/2005
12	polyethylene glycol 1000IBA 09/2019 - 05/2010
9	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 04/2015
9	PolymersIBA 03/2021 - 11/2013
7	LigandsIBA 01/2022 - 04/2006
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 02/2013
7	VaccinesIBA 10/2021 - 04/2013
7	Neuregulin-1 (Neuregulin 1)IBA 01/2018 - 06/2008
6	Silicon Dioxide (Silica)FDA LinkGeneric 10/2021 - 02/2016
6	Messenger RNA (mRNA)IBA 01/2021 - 01/2015
6	Therapeutic UsesIBA 10/2020 - 01/2014
6	Small Interfering RNA (siRNA)IBA 01/2020 - 08/2011
6	caprolactoneIBA 10/2015 - 09/2009
5	HydrogelsIBA 11/2022 - 05/2014
5	Netrin ReceptorsIBA 01/2021 - 11/2004
5	NetrinsIBA 01/2021 - 01/2008
5	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2018
5	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2020 - 11/2013
5	NanocapsulesIBA 01/2019 - 01/2017
5	muskIBA 01/2018 - 10/2008
5	LDL Receptors (LDL Receptor)IBA 01/2018 - 12/2013
5	Paclitaxel (Taxol)FDA LinkGeneric 03/2013 - 01/2007
5	Poloxamer (Poloxamer 407)IBA 06/2010 - 06/2009
4	Amyloid (Amyloid Fibrils)IBA 06/2021 - 05/2011
4	Peptides (Polypeptides)IBA 10/2020 - 05/2011
4	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2015
4	Folic Acid (Vitamin M)FDA LinkGeneric 05/2019 - 06/2015
4	Protein Isoforms (Isoforms)IBA 01/2019 - 09/2007
4	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2012
4	Polyglactin 910IBA 01/2016 - 05/2010
4	Cholic AcidIBA 07/2015 - 08/2013
4	Prostaglandins AIBA 01/2015 - 10/2011
3	Biological ProductsIBA 01/2022 - 06/2008
3	Biocompatible Materials (Biomaterials)IBA 10/2021 - 11/2013
3	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2018
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021 - 08/2011
3	CytokinesIBA 01/2021 - 06/2008
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
3	ParvalbuminsIBA 01/2021 - 12/2011
3	TensinsIBA 01/2021 - 08/2011
3	MicellesIBA 10/2020 - 11/2014
3	peripheral membrane protein 43KIBA 01/2020 - 12/2016
3	gamma-Aminobutyric Acid (GABA)IBA 12/2019 - 01/2010
3	LipidsIBA 01/2019 - 04/2003
3	Granzymes (Granzyme)IBA 01/2018 - 11/2015
3	Ethylene Glycol (Monoethylene Glycol)IBA 06/2017 - 09/2014
3	Lipoproteins (Lipoprotein)IBA 06/2017 - 04/2012
3	Chloroquine (Aralen)FDA LinkGeneric 01/2017 - 01/2014
3	Phosphotransferases (Kinase)IBA 01/2017 - 11/2004
3	AutoantibodiesIBA 01/2015 - 04/2012
3	polycaprolactoneIBA 08/2014 - 06/2009
2	Hydroxyl RadicalIBA 12/2022 - 01/2021
2	PolyphenolsIBA 11/2022 - 10/2020
2	AntioxidantsIBA 04/2022 - 01/2022
2	GoldIBA 04/2022 - 12/2013
2	Glutathione (Reduced Glutathione)IBA 01/2022 - 01/2021
2	EnzymesIBA 01/2022 - 01/2019

Therapy/Procedure

64	Therapeutics 12/2022 - 06/2008
28	Drug Therapy (Chemotherapy) 01/2022 - 09/2009
10	Immunotherapy 01/2022 - 01/2013
8	Photothermal Therapy 12/2022 - 10/2018
7	Quantum Dots (Quantum Dot) 03/2021 - 01/2019
4	Precision Medicine 04/2022 - 01/2017
3	Lasers (Laser) 01/2019 - 09/2014